Prio Wealth Limited Partnership Decreases Stock Holdings in AMETEK, Inc. (NYSE:AME)

Prio Wealth Limited Partnership decreased its position in AMETEK, Inc. (NYSE:AME) by 17.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 15,000 shares of the technology company’s stock after selling 3,200 shares during the quarter. Prio Wealth Limited Partnership’s holdings in AMETEK were worth $1,362,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Cornerstone Advisors Inc. increased its position in shares of AMETEK by 55.2% in the first quarter. Cornerstone Advisors Inc. now owns 388 shares of the technology company’s stock valued at $32,000 after acquiring an additional 138 shares during the period. Liberty Wealth Management LLC purchased a new position in shares of AMETEK during the first quarter valued at about $40,000. Legacy Advisors LLC purchased a new position in shares of AMETEK during the second quarter valued at about $55,000. Financial Gravity Wealth Inc. purchased a new position in shares of AMETEK during the first quarter valued at about $73,000. Finally, Barrett Asset Management LLC increased its position in shares of AMETEK by 100.0% during the first quarter. Barrett Asset Management LLC now owns 1,682 shares of the technology company’s stock valued at $140,000 after buying an additional 841 shares during the period. Hedge funds and other institutional investors own 85.82% of the company’s stock.

In related news, Director Thomas A. Amato sold 1,790 shares of the business’s stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $83.57, for a total transaction of $149,590.30. Following the sale, the director now owns 9,370 shares of the company’s stock, valued at $783,050.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider David A. Zapico sold 58,760 shares of the business’s stock in a transaction dated Tuesday, June 11th. The stock was sold at an average price of $86.35, for a total transaction of $5,073,926.00. Following the sale, the insider now directly owns 258,226 shares in the company, valued at approximately $22,297,815.10. The disclosure for this sale can be found here. Insiders have sold 93,370 shares of company stock worth $8,072,702 in the last three months. 0.80% of the stock is currently owned by insiders.

NYSE:AME traded up $0.10 during mid-day trading on Wednesday, hitting $90.85. 216,338 shares of the company’s stock were exchanged, compared to its average volume of 1,173,475. AMETEK, Inc. has a one year low of $63.14 and a one year high of $92.30. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.27 and a current ratio of 1.91. The company has a fifty day moving average price of $88.98. The stock has a market cap of $20.34 billion, a P/E ratio of 27.61, a PEG ratio of 2.28 and a beta of 1.24.

AMETEK (NYSE:AME) last posted its quarterly earnings data on Tuesday, July 30th. The technology company reported $1.05 EPS for the quarter, topping the consensus estimate of $1.03 by $0.02. AMETEK had a net margin of 16.14% and a return on equity of 18.56%. The business had revenue of $1.29 billion for the quarter, compared to analyst estimates of $1.32 billion. During the same quarter in the previous year, the firm posted $0.83 earnings per share. AMETEK’s quarterly revenue was up 6.7% on a year-over-year basis. Equities analysts predict that AMETEK, Inc. will post 4.07 earnings per share for the current fiscal year.

Several brokerages recently issued reports on AME. BMO Capital Markets upgraded shares of TMAC Resources from a “market perform” rating to an “outperform” rating in a research report on Thursday, May 2nd. Berenberg Bank reiterated a “buy” rating and set a GBX 150 ($1.96) price target on shares of Tharisa in a research report on Wednesday, May 15th. Morgan Stanley reiterated a “buy” rating and set a $60.00 price target on shares of The Coca-Cola in a research report on Wednesday. DA Davidson upgraded shares of Domtar from a “neutral” rating to a “buy” rating in a research report on Thursday, May 2nd. Finally, ValuEngine cut shares of Zosano Pharma from a “buy” rating to a “hold” rating in a research report on Wednesday, May 1st. Fifteen analysts have rated the stock with a buy rating, The company presently has an average rating of “Buy” and an average price target of $91.67.

AMETEK Profile

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices worldwide. The company's Electronic Instruments segment offers advanced instruments for the process, aerospace, power, and industrial markets; process control instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; and instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets.

See Also: S&P 500 Index

Institutional Ownership by Quarter for AMETEK (NYSE:AME)

Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.